220 related articles for article (PubMed ID: 11282214)
1. Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes.
Komoto S; Kinomoto M; Ibrahim MS; Zhong Q; Auwanit W; Ayuthaya PI; Otake T; Mori H; Oishi I; Kurosu T; Takahashi H; Mukai T; Ikuta K
Vaccine; 2001 Apr; 19(20-22):3019-32. PubMed ID: 11282214
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients.
Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E
J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634
[TBL] [Abstract][Full Text] [Related]
4. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
[TBL] [Abstract][Full Text] [Related]
5. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nef.
Neurath AR; Strick N; Kolbe H; Kieny MP; Girard M; Jiang S
Mol Immunol; 1991 Sep; 28(9):965-73. PubMed ID: 1717841
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
[TBL] [Abstract][Full Text] [Related]
7. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
9. Nef and Gag synthetic peptide priming of antibody responses to HIV type 1 antigens in mice and primates.
Vaslin B; Claverie JM; Benveniste O; Barre-Sinoussi FC; Dormont D
AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1241-50. PubMed ID: 7531460
[TBL] [Abstract][Full Text] [Related]
10. Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopes.
Van der Ryst E; Nakasone T; Habel A; Venet A; Gomard E; Altmeyer R; Girard M; Borman AM
Res Virol; 1998; 149(1):5-20. PubMed ID: 9561560
[TBL] [Abstract][Full Text] [Related]
11. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
[TBL] [Abstract][Full Text] [Related]
12. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
[TBL] [Abstract][Full Text] [Related]
13. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.
Siakkou H; Jahn S; Kienzle N; Ulrich R; Grötzinger C; Schneider T; Kohleisen B; Pauli G; Spohn R; Jung G
Arch Virol; 1993; 128(1-2):81-95. PubMed ID: 7678193
[TBL] [Abstract][Full Text] [Related]
15. Epitope mapping of murine monoclonal antibodies against human immunodeficiency virus type 1 Nef.
Otake K; Fujii Y; Tashiro M; Adachi A; Kitoh J
Exp Anim; 1997 Jan; 46(1):53-8. PubMed ID: 9027472
[TBL] [Abstract][Full Text] [Related]
16. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype.
Geldmacher C; Currier JR; Gerhardt M; Haule A; Maboko L; Birx D; Gray C; Meyerhans A; Cox J; Hoelscher M
AIDS; 2007 Jan; 21(2):135-43. PubMed ID: 17197803
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
18. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
[TBL] [Abstract][Full Text] [Related]
19. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
[TBL] [Abstract][Full Text] [Related]
20. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
